Published in J Infect Dis on January 01, 1983
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob Agents Chemother (1986) 2.12
In vitro susceptibilities of four species of coagulase-negative staphylococci. Antimicrob Agents Chemother (1986) 1.80
Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis (2004) 1.51
Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol (1984) 1.33
In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs. Antimicrob Agents Chemother (1987) 1.32
Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1986) 1.18
In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1985) 1.05
Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections. Infection (1985) 0.98
Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts. Antimicrob Agents Chemother (1991) 0.95
Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections. West J Med (1984) 0.94
Autobac susceptibility testing of methicillin-resistant Staphylococcus aureus isolated in an Australian hospital. J Clin Microbiol (1985) 0.90
Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.86
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med (1980) 4.45
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03
Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci (1968) 3.03
Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. J Immunol (1972) 2.89
Limitations of the usefulness of the Limulus assay for endotoxin. N Engl J Med (1973) 2.84
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis (1978) 2.72
The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med (1975) 2.63
Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med (1981) 2.56
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med (1972) 2.42
Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) (1984) 2.28
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med (1992) 2.25
Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med (1988) 2.17
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med (1987) 2.04
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis (1986) 2.04
Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med (1997) 2.00
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet (1986) 1.96
Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis (1999) 1.75
Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population. J Clin Microbiol (1979) 1.71
Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med (1973) 1.70
The relation of K-antigen to virulence of Escherichia coli. J Infect Dis (1975) 1.64
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.59
Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med (1988) 1.58
Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. Infect Immun (1977) 1.56
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infect Immun (1979) 1.41
Nephrotoxicity associated with cephalothin administration. Arch Intern Med (1975) 1.40
Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. Infect Immun (1977) 1.39
An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA (1980) 1.38
Bacteremia due to Fusobacterium species. Am J Med (1983) 1.35
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control (1984) 1.33
Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol (2009) 1.33
Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA (1984) 1.31
Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis (1983) 1.29
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901. J Immunol (1973) 1.28
"Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med (1969) 1.28
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Meningitis caused by gram-negative bacilli. Ann Intern Med (1980) 1.27
Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis (1976) 1.24
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Nosocomial dermatitis and pruritus caused by pigeon mite infestation. Arch Intern Med (1987) 1.21
Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum. Infect Immun (1987) 1.20
Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis (1987) 1.19
Survey of AIDS knowledge and behavior changes among Massachusetts adults. Prev Med (1989) 1.15
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med (1984) 1.14
Immunofluorescent demonstration of the common enterobacterial antigen. Proc Soc Exp Biol Med (1966) 1.12
Risk factors for nosocomial pneumonia. Focus on prophylaxis. Med Clin North Am (2001) 1.12
Serogroup identification of meningococci by a modified antiserum agar method. J Clin Microbiol (1979) 1.12
Meningitis caused by Acinetobacter calcoaceticus var anitratus. A specific hazard in neurosurgical patients. Arch Neurol (1981) 1.11
Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun (1982) 1.10
Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs (2001) 1.10
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria. J Infect Dis (1977) 1.07
Knowledge about HIV and behavioral risks of foreign-born Boston public school students. Am J Public Health (1991) 1.07
Occupational hazards to hospital personnel. Ann Intern Med (1985) 1.07
A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. Am J Epidemiol (1984) 1.06
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) (1990) 1.05
Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J Infect Dis (1988) 1.04
The Boston AIDS Survival Score (BASS): a multidimensional AIDS severity instrument. Am J Public Health (1997) 1.00
Use of paper-absorbed fingerstick blood samples for studies of antibody to human immunodeficiency virus type 1 in intravenous drug users. J Infect Dis (1990) 1.00
Gram-negative bacteremia. Adv Intern Med (1974) 1.00
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making (1998) 0.99
Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol (2001) 0.97
Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole. J Med Vet Mycol (1996) 0.94
Contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia? Am Rev Respir Dis (1984) 0.93
Common enterobacterial antigen. 3. Initial titers and antibody response in bacteremia caused by gram-negative bacilli. Infect Immun (1973) 0.93
Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions. J Lab Clin Med (1967) 0.93
Changes in insurance status and access to care for persons with AIDS in the Boston Health Study. Am J Public Health (1994) 0.92
Familial multiple endocrine adenomatosis. Multiple endocrine neoplasia, type I. Arch Intern Med (1972) 0.92
Endotoxin and bacteremia due to gram-negative organisms. N Engl J Med (1970) 0.91
Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects. J Infect Dis (1986) 0.90
Contamination of mechanical ventilators with tubing changes every 24 or 48 hours. N Engl J Med (1982) 0.89
Bacterial interference induced in embryonated eggs by staphylococci. J Clin Invest (1967) 0.88
Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli. Infect Immun (1973) 0.87
Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practice. Am J Obstet Gynecol (1992) 0.87